1, according to the law brother network shows: Class A drugs and Class B drugs are social health insurance (referred to as health insurance, including urban and rural residents health insurance, employee health insurance, etc.) artificially to the classification of drugs made. Medicare classifies drugs into three categories: Class A, Class B, and Class C.
2, for example, some kind of medical insurance reimbursement rate is 80%, a drug belongs to the medical insurance provisions of the drug class A, assuming that the price of the drug is 100 yuan / box, the use of medical insurance will be reimbursed 80%, that is, 80 yuan, the need for out-of-pocket expenses of 20 yuan; if the price of a class B drugs are also 100 yuan / box, the proportion of co-payment (class B drugs have a co-payment ratio, different class B drugs co-payment ratio) is 15%, the medical insurance will not be able to pay the price of the drug class B, the price of the drug class B, the co-payment ratio is 15%. If the price of a Class B drug is also 100 yuan per box, the deductible (Class B drugs have a deductible, and different Class B drugs have different deductibles) is 15%, the health insurance reimbursement will first remove the 15% of the deductible (15% of 100 yuan is 15 yuan), and then reimbursement of the remaining 85% (that is, 85 yuan) will be based on 80%, that is, reimbursement of 85 x 80% = 68 yuan, and out-of-pocket expenses of 32 yuan. Category A drugs are usually those that are efficacious, inexpensive, and can ensure the basic needs of clinical treatment.
3. Article 31 of the Medical Security Law (Draft for Comment) establishes a centralized procurement system for drugs and medical consumables for public medical institutions. The administrative department of medical security formulates bidding and procurement policies for drugs and medical consumables and supervises their implementation, guiding the construction of centralized procurement platforms for drugs and medical consumables. The provincial medical security administrative department organizes public medical institutions under its jurisdiction to carry out centralized procurement of drugs and medical consumables and supervises the implementation thereof, and establishes a centralized procurement platform in accordance with the unified planning and standards of the State Council's administrative department of medical security, which is managed by the provincial centralized purchasing agency. The provincial centralized purchasing agencies shall implement the transaction rules and standards formulated by the administrative department of medical security, carry out the bidding, purchasing, transaction and settlement of medicines and medical consumables, and monitor the relevant information. Public medical institutions shall purchase the required drugs and medical consumables from the provincial centralized purchasing platform in accordance with regulations. The state encourages non-public medical institutions to participate in centralized procurement of drugs and medical consumables.